Nasdaq · CIK 0001530766
STEX BioSig Technologies, Inc.
Insider trading from SEC Form 4. Last filing 5 d ago. Close $0.49 on Oct 9, 2026, 0% from the 52-week low and -92% from the high.
Last 90 days
Net insider value
-$95k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
3
$95k by 2 insiders
Insiders on file
8
with a Form 4 at this company
Price and insider trades, last year
STEXOct 9, 2026 · close 0.49
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BioSig Technologies, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Christine Marie Plummer Chief Financial Officer sell | $7,175 13,344 shares | -3% | +6% from low-90% from high | |
| 29Weak | Mitchell Young Williams Chief Investment Officer sell | $35k 65,538 shares | -2% | +6% from low-90% from high | |
| 22Weak | Mitchell Young Williams Chief Investment Officer sell | $52k 72,689 shares | -2% | - |
Transactions
The last 13 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Mitchell Young Williams Chief Investment Officer | SOpen-market sale Common Stock | -65,538 | $0.54 | $35k | 2,820,276 | 5 d ago |
| Aug 1, 2026 | Christine Marie Plummer Chief Financial Officer | FTax withholding Common stock | -11,508 | $0.71 | $8,170 | 474,989 | 5 d ago |
| Oct 1, 2026 | Christine Marie Plummer Chief Financial Officer | SOpen-market sale Common Stock | -13,344 | $0.54 | $7,175 | 461,645 | 5 d ago |
| Aug 1, 2026 | Mitchell Young Williams Chief Investment Officer | FTax withholding Common Stock | -55,335 | $0.71 | $39k | 2,958,503 | 39 d ago |
| Sep 2, 2026 | Mitchell Young Williams Chief Investment Officer | SOpen-market sale Common Stock | -72,689 | $0.72 | $52k | 2,885,814 | 39 d ago |
| May 29, 2025 | Anthony N. Amato Chief Executive Officer | AGrant or award Common Stock | +900,000 | $0.00 | $0 | 3,031,547 | Jun 2, 2025 |
| May 29, 2025 | Ferdinand Groenewald Interim CFO | AGrant or award Common Stock | +175,000 | $0.00 | $0 | 235,000 | Jun 2, 2025 |
| Apr 24, 2025 | Steven Eric Abelman director | AGrant or award Common Stock | +23,345 | $0.00 | $0 | 103,345 | Apr 29, 2025 |
| Apr 24, 2025 | Anthony N. Amato Chief Executive Officer | AGrant or award Common Stock | +23,345 | $0.00 | $0 | 2,131,547 | Apr 29, 2025 |
| Apr 24, 2025 | Christopher Allen Baer director | AGrant or award Common Stock | +23,345 | $0.00 | $0 | 103,345 | Apr 29, 2025 |
| Apr 24, 2025 | Donald Browne director | AGrant or award Common Stock | +23,345 | $0.00 | $0 | 103,345 | Apr 29, 2025 |
| Apr 24, 2025 | Ferdinand Groenewald Interim CFO | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 60,000 | Apr 29, 2025 |
| Apr 24, 2025 | Frederick Hrkac director | AGrant or award Common Stock | +23,345 | $0.00 | $0 | 612,846 | Apr 29, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Steven Eric Abelmandirector
- Anthony N. AmatoChief Executive Officer
- Christopher Allen Baerdirector
- Donald Brownedirector
- Ferdinand GroenewaldInterim CFO
- Frederick Hrkacdirector
- Christine Marie PlummerChief Financial Officer
- Mitchell Young WilliamsChief Investment Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.